NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









HerAnova Lifesciences

HerAnova Lifesciences

Private
Burlington, MassachusettsHealthcare & Life Scienceshttps://heranova.com/

Last Round

Seed

Dec 28, 2023

Total Funding Raised

$13.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

HerAnova Lifesciences is a biotechnology company that develops non-invasive diagnostics and integrated care solutions for women's health, with a focus on endometriosis and infertility.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices

Business Model

B2B2C

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

endometriosis diagnosticwomen's healthmulti-omicblood-based diagnosticprecision medicinefemtechreproductive healthnon-invasive testingbiotechnologydiagnostic assaymachine learningbiomarkersclinical diagnosticsmedical devicesAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HerAnova Lifesciences Comps

Public and private peers based on sector, stage, and business model.

HerAnova Lifesciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HerAnova Lifesciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 28, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Yining Zhao

Co-Founder And CEO

Founding Team

HerAnova Lifesciences Investors

Notable investors and investment history

HerAnova Lifesciences investors
InvestorRounds
Emerging Technology PartnersSeed
Triwise CapitalSeed
Sinovation VenturesSeed
Pivotal bioVenture Partners ChinaSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 30% MoM, reaching 3K.

  • Mar 16, 2026

    Presenting a late-breaking abstract at the AGCES 2026 Annual Meeting.

View all signals

HerAnova Lifesciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HerAnova Lifesciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HerAnova Lifesciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlington, Massachusetts
Employee Range21
Year Founded2022
Last FundingDec 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.